Mark C. Sulavik
University of Michigan
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark C. Sulavik.
Antimicrobial Agents and Chemotherapy | 2001
Mark C. Sulavik; Chad Houseweart; Christina Cramer; Nilofer Jiwani; Nicholas J. Murgolo; Jonathan Greene; Beth DiDomenico; K J Shaw; George H. Miller; Roberta S. Hare; George H. Shimer
ABSTRACT The contribution of seven known and nine predicted genes or operons associated with multidrug resistance to the susceptibility of Escherichia coli W3110 was assessed for 20 different classes of antimicrobial compounds that include antibiotics, antiseptics, detergents, and dyes. Strains were constructed with deletions for genes in the major facilitator superfamily, the resistance nodulation-cell division family, the small multidrug resistance family, the ATP-binding cassette family, and outer membrane factors. The agar dilution MICs of 35 compounds were determined for strains with deletions for multidrug resistance (MDR) pumps. Deletions in acrAB or tolC resulted in increased susceptibilities to the majority of compounds tested. The remaining MDR pump gene deletions resulted in increased susceptibilities to far fewer compounds. The results identify which MDR pumps contribute to intrinsic resistance under the conditions tested and supply practical information useful for designing sensitive assay strains for cell-based screening of antibacterial compounds.
Journal of Bacteriology | 2006
Michael A. D'Elia; Mark P. Pereira; Yu Seon Chung; Wenjun Zhao; Andrew S. Chau; Teresa J. Kenney; Mark C. Sulavik; Todd A. Black; Eric D. Brown
An extensive study of teichoic acid biosynthesis in the model organism Bacillus subtilis has established teichoic acid polymers as essential components of the gram-positive cell wall. However, similar studies pertaining to therapeutically relevant organisms, such as Staphylococcus aureus, are scarce. In this study we have carried out a meticulous examination of the dispensability of teichoic acid biosynthetic enzymes in S. aureus. By use of an allelic replacement methodology, we examined all facets of teichoic acid assembly, including intracellular polymer production and export. Using this approach we confirmed that the first-acting enzyme (TarO) was dispensable for growth, in contrast to dispensability studies in B. subtilis. Upon further characterization, we demonstrated that later-acting gene products (TarB, TarD, TarF, TarIJ, and TarH) responsible for polymer formation and export were essential for viability. We resolved this paradox by demonstrating that all of the apparently indispensable genes became dispensable in a tarO null genetic background. This work suggests a lethal gain-of-function mechanism where lesions beyond the initial step in wall teichoic acid biosynthesis render S. aureus nonviable. This discovery poses questions regarding the conventional understanding of essential gene sets, garnered through single-gene knockout experiments in bacteria and higher organisms, and points to a novel drug development strategy targeting late steps in teichoic acid synthesis for the infectious pathogen S. aureus.
Journal of Bacteriology | 2001
Roberta S. Hare; Scott S. Walker; Thomas E. Dorman; Jonathan Greene; Luz-Maria Guzman; Teresa J. Kenney; Mark C. Sulavik; Khandan Baradaran; Chad Houseweart; Haiying Yu; Zuzana Foldes; Anna Motzer; Michael Walbridge; George H. Shimer; K J Shaw
In vivo genetic footprinting was developed in the yeast Saccharomyces cerevisiae to simultaneously assess the importance of thousands of genes for the fitness of the cell under any growth condition. We have developed in vivo genetic footprinting for Escherichia coli, a model bacterium and pathogen. We further demonstrate the utility of this technology for rapidly discovering genes that affect the fitness of E. coli under a variety of growth conditions. The definitive features of this system include a conditionally regulated Tn10 transposase with relaxed sequence specificity and a conditionally regulated replicon for the vector containing the transposase and mini-Tn10 transposon with an outwardly oriented promoter. This system results in a high frequency of randomly distributed transposon insertions, eliminating the need for the selection of a population containing transposon insertions, stringent suppression of transposon mutagenesis, and few polar effects. Successful footprints have been achieved for most genes longer than 400 bp, including genes located in operons. In addition, the ability of recombinant proteins to complement mutagenized hosts has been evaluated by genetic footprinting using a bacteriophage lambda transposon delivery system.
Journal of Bacteriology | 1999
Florence Y. An; Mark C. Sulavik; Don B. Clewell
Journal of Bacteriology | 1992
Mark C. Sulavik; G Tardif; Don B. Clewell
American Journal of Pathology | 1983
Peter A. Ward; Ricardo E. Duque; Mark C. Sulavik; Kent J. Johnson
Journal of Bacteriology | 1996
Mark C. Sulavik; Don B. Clewell
American Journal of Pathology | 1984
Peter A. Ward; Mark C. Sulavik; Kent J. Johnson
Fems Microbiology Letters | 1993
Virginia D. Wells; Cindy L. Munro; Mark C. Sulavik; Don B. Clewell; Francis L. Macrina
Chest | 1983
Sem H. Phan; Gregg Armstrong; Mark C. Sulavik; Denis Schrier; Kent J. Johnson; Peter A. Ward